Last reviewed · How we verify

NCT06294665

Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block

Status unknown Phase 1 Last updated 5 March 2024
What this trial tests

Phase 1 trial testing Pericapsular Nerve Group (PENG) Block in Hip Fractures in 60 participants. Status unknown.

Timeline
1 March 2024
Primary endpoint
1 December 2024
1 January 2025

Quick facts

Lead sponsorAin Shams University
PhasePhase 1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 March 2024
Primary completion1 December 2024
Estimated completion1 January 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Hip Fractures or Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work is to compare the effectiveness of bupivacaine- dexmedetomidine mixture versus bupivacaine-dexamethasone mixture in PENG Block as Post-operative Analgesia in Hip surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pericapsular Nerve Group (PENG) Block

Trials testing the same drug.

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06294665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing